TREVICTA 525
Active ingredient: paliperidone palmitate
Dosage form: prolonged-release suspension for injection
Type of dosage: intramuscular injection
Mechanism of action: paliperidone is a long-acting injectable antipsychotic medication that works by blocking dopamine D2 receptors in the brain. Dopamine is a neurotransmitter that plays a role in regulating mood, thinking, and behavior. By blocking dopamine receptors, paliperidone can help to reduce psychotic symptoms such as delusions, hallucinations, and disorganized thinking.
Uses: TREVICTA is used for the maintenance treatment of schizophrenia in adults. It is administered once every 3 months, so it is a convenient option for people who have difficulty taking daily medications.
How to use: TREVICTA must be injected intramuscularly by a healthcare professional. It should be injected slowly and deeply into the deltoid or gluteal muscle.
Important safety information:
TREVICTA can cause serious side effects, including tardive dyskinesia, a movement disorder that can be permanent.
TREVICTA may also increase the risk of death in elderly people with dementia-related psychosis.
TREVICTA should be used with caution in people with heart disease, diabetes, or seizures.
TREVICTA may interact with other medications, so it is important to tell your healthcare professional about all of the medications you are taking.
If you have any questions or concerns about TREVICTA, please talk to your healthcare professional.